Precision Medicine for CAR T-Cell Care

If you have certain types of cancer, such as lymphoma or leukemia, but are no longer responding to traditional treatment, you may be a candidate for chimeric antigen receptor T-cell therapy, also known as CAR T-cell therapy.

CAR T-cell therapy uses immune cells from your body to target cancer cells. During treatment, our cancer experts collect your white blood cells and alter them so that they can better identify cancer cells. The altered cells are infused back into your bloodstream, where they can help destroy cancer cells. Chemotherapy may be used in combination with CAR T-cell treatment.

We offer CAR T-cell therapies such as:

• Axicabtagene ciloleucel (Yescarta) — For follicular lymphoma and large B-cell non-Hodgkin’s lymphoma
• Brexucabtagene autoleucel (Tecartus) — For adults with mantle cell lymphoma and acute lymphoblastic leukemia

Why Choose Us for CAR T-Cell Treatment

• Our physicians are leading providers of medical care for cancers that affect the blood and bone marrow.
• Our team is part of USC Norris Comprehensive Cancer Center, which is consistently ranked as one of the best cancer care providers in the country by U.S. News & World Report.
• We are pioneers in cancer research, giving you access to innovative clinical trials and the latest breakthroughs in medications and treatment options.
• We use the latest precision-medicine techniques, like CAR T-cell therapy, to give you advanced, patient-centered care.
• In addition to CAR T-cell therapy, our cancer specialists deliver a wide range of other treatment therapies, including chemotherapy and other immunotherapies.